Category : Press releases

Doxamed (formerly Loxamed) supports local authorities at every stage in the implementation of a medical project. From consulting to implementation, Doxamed (formerly Loxamed) has developed a territorial health organization and cooperation approach that facilitates and improves the healthcare pathway for people with difficulties accessing care. Doxamed (formerly Loxamed) integrates and brings together all the stakeholders in the ecosystem: healthcare professionals and territorial organizations such as the CPTS, elected representatives, the Region, EPCIs, Departmental Councils, the ARS, the DCGDR and the Caisses d'Assurance Maladie. 

Doxamed (formerly Loxamed) offers a service for anyone who has completed a full course of vaccinations outside a country that issues vaccination certificates in the European format, to convert their original vaccination pass into a European pass. This equivalence is compulsory for residents of many countries1. In order to be authorized to enter France and most other European countries, French nationals living abroad must now obtain an equivalent European pass.

In this period of record epidemic resurgence, the town of Le Chesnay-Rocquencourt has made every effort to ensure the safety of its residents and visitors to the Westfield Parly 2 shopping center in the commune. In partnership with Doxamed (formerly Loxamed) and Cerballiance laboratories, and with financial support from the Ile-de-France region, the town decided to install an RT-PCR screening system at the heart of the Westfield Parly 2 shopping center, which receives over 12 million visits a year.

Against a backdrop of intense spread of the virus, and in order to meet the high demand for screening, the city of Versailles has called on Doxamed (formerly Loxamed) to deploy a mobile, operational covid test system in the heart of the town, for the benefit of all residents.

Doxamed (ex Loxamed) installs a screening facility at the heart of the Chamrousse ski resort, reinforcing the town's health resources during this period of high tourist attraction. Against a backdrop of strong pandemic resurgence, ski resorts are preparing to enter the busiest tourist season of the year. They are faced with the need to strengthen their medical resources to meet the very high demand for screening.

Doxamed (formerly Loxamed), a company specializing in mobility and medical technology, has developed a Health Hub with the town of Louveciennes. Within this Hub, healthcare professionals offer RT-PCR tests, antigenic tests and teleconsultation. Doxamed (formerly Loxamed) also supports pharmacies as part of the vaccination campaign, with the help of the town council.

Doxamed (ex Loxamed), a company specializing in mobility and medical technology, will be taking part in the Salon des Maires, from November 16 to 18, 2021. A stand dedicated to the company will be set up in pavilion 2.2. Health-related issues will be at the heart of the show. The health inequalities revealed during the pandemic, the issue of medical deserts and access to care, are essential and urgent challenges for municipalities and local authorities.

Doxamed (formerly Loxamed), a company specializing in medical mobility, has been present since the beginning of the health crisis, deploying high-performance screening and telemedicine solutions throughout the country, in stations, stadiums, amusement parks, local authorities and businesses, in the form of mobile boxes, mobile trucks or solid installations.

Since Monday August 9, Doxamed (formerly Loxamed) has been present at 11 new railway stations, including Metz Ville, Nancy, Paris Montparnasse 1 and 2, Strasbourg, Le Mans and Toulouse, offering Covid antigenic screening to make the summer period even safer, and to facilitate the implementation of the health pass in transport.

Following the French President's statements on July 12, announcing the implementation of the health pass in leisure and cultural venues, Parc Asterix (Oise), in partnership with LOXAMED, has decided to install, at the park entrance and from July 21, 2021, a specific screening device, with the aim of securing and facilitating access to the park for future visitors.